Regentatlantic Capital LLC Abb Vie Inc. Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Regentatlantic Capital LLC holds 86,356 shares of ABBV stock, worth $15.2 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

86,356

Previous 88,341 2.25%

Holding current value

$15.2 Million

Previous $13.5 Million 14.34%

% of portfolio

0.35%

Previous 0.45%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $266,406 - $305,551	-1,985 Reduced 2.25%	86,356 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $632,501 - $804,116	4,596 Added 5.49%	88,341 $13.5 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $394,884 - $489,940	2,992 Added 3.71%	83,745 $13.6 Million
Q4 2021 Jan 27, 2022	BUY	$107.43 - $135.93 $127,089 - $160,805	1,183 Added 1.49%	80,753 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $631,696 - $717,070	5,937 Added 8.06%	79,570 $8.58 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $833,684 - $928,772	7,924 Added 12.06%	73,633 $8.29 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $763,158 - $840,145	7,460 Added 12.81%	65,709 $7.11 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $585,242 - $790,139	7,271 Added 14.26%	58,249 $6.24 Million
Q3 2020 Oct 13, 2020	BUY	$85.91 - $100.83 $1.76 Million - $2.06 Million	20,451 Added 66.99%	50,978 $4.47 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $748,594 - $1 Million	10,203 Added 50.2%	30,527 $3 Million
Q1 2020 May 14, 2020	SELL	$64.5 - $97.79 $2.27 Million - $3.44 Million	-35,167 Reduced 63.37%	20,324 $1.55 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $7,285 - $9,115	-101 Reduced 0.18%	55,491 $4.91 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $16,500 - $19,838	262 Added 0.47%	55,592 $4.21 Million
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $10,577 - $13,520	-161 Reduced 0.29%	55,330 $4.02 Million
Q1 2019 May 03, 2019	BUY	$77.14 - $90.79 $339,801 - $399,929	4,405 Added 8.62%	55,491 $4.47 Million
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $2.81 Million - $3.46 Million	36,080 Added 240.44%	51,086 $4.71 Million
Q3 2018 Oct 30, 2018	BUY	$88.91 - $98.84 $90,332 - $100,421	1,016 Added 7.26%	15,006 $1.42 Million
Q2 2018 Jul 31, 2018	SELL	$89.78 - $106.23 $4,489 - $5,311	-50 Reduced 0.36%	13,990 $1.3 Million
Q1 2018 Apr 23, 2018	SELL	$92.01 - $123.21 $82,440 - $110,396	-896 Reduced 6.0%	14,040 $1.33 Million
Q4 2017 Jan 23, 2018	SELL	$89.56 - $98.21 $127,623 - $139,949	-1,425 Reduced 8.71%	14,936 $1.44 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $1.14 Million - $1.46 Million	16,361	16,361 $1.45 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Abb Vie Inc. Transaction History